BACKGROUND: There are 2.3 million children living with HIV worldwide, almost 90 % of whom live in sub-Saharan Africa. Access to antiretroviral therapy (ART) for HIV treatment has dramatically increased in resource-limited settings in recent years and allows more HIV-infected children to survive into adolescence and adulthood. PURPOSE: Our objective was to improve the understandability of pediatric antiretroviral adherence measurement items for use in resource-limited settings through cognitive interviewing with pediatric caregivers and HIV-infected adolescents in Kenya. METHODS: We compiled adherence measurement items through a systematic literature review and qualitative work. We conducted cognitive interviews assessing the items with caregivers of HIV-infected children enrolled in HIV care in Kenya and conducted group cognitive assessments with HIV-infected adolescents. We used verbal probing and guided "thinking aloud" to evaluate relevance, comprehension, recall, and sensitivity/acceptability. Analysis followed a systematic sequence of review, compiling data by item, and coding responses. RESULTS: We interviewed 21 Kenyan parents and guardians and 10 adolescents (mean age 15 years, SD 1.8) on antiretroviral therapy for a mean of 3.6 years. Cognitive interviews optimized item-response options, wording, and content. Some participants demonstrated difficulty with "think aloud" processes, but verbal probes were easily answered. Comprehension problems were found for key language concepts such "missed doses" and "having side effects." Key findings for response options included differences among responses to various recall periods, with preferences for the shortest (one 24-h day) and longest recall periods (1 month); difficulty describing specific drug information; benefits for including normalizing statements before asking for sensitive information; and challenges processing categorical frequency scales. Important content areas for inclusion included dose timing, disclosure, stigma, and food insecurity. CONCLUSIONS: Cognitive interviewing is a productive strategy for increasing the face validity and understandability of adherence measurement items, particularly across cultures. Interviews in Kenya suggested adherence measurement modifications of relevance for other resource-limited settings.
BACKGROUND: There are 2.3 million children living with HIV worldwide, almost 90 % of whom live in sub-Saharan Africa. Access to antiretroviral therapy (ART) for HIV treatment has dramatically increased in resource-limited settings in recent years and allows more HIV-infectedchildren to survive into adolescence and adulthood. PURPOSE: Our objective was to improve the understandability of pediatric antiretroviral adherence measurement items for use in resource-limited settings through cognitive interviewing with pediatric caregivers and HIV-infected adolescents in Kenya. METHODS: We compiled adherence measurement items through a systematic literature review and qualitative work. We conducted cognitive interviews assessing the items with caregivers of HIV-infectedchildren enrolled in HIV care in Kenya and conducted group cognitive assessments with HIV-infected adolescents. We used verbal probing and guided "thinking aloud" to evaluate relevance, comprehension, recall, and sensitivity/acceptability. Analysis followed a systematic sequence of review, compiling data by item, and coding responses. RESULTS: We interviewed 21 Kenyan parents and guardians and 10 adolescents (mean age 15 years, SD 1.8) on antiretroviral therapy for a mean of 3.6 years. Cognitive interviews optimized item-response options, wording, and content. Some participants demonstrated difficulty with "think aloud" processes, but verbal probes were easily answered. Comprehension problems were found for key language concepts such "missed doses" and "having side effects." Key findings for response options included differences among responses to various recall periods, with preferences for the shortest (one 24-h day) and longest recall periods (1 month); difficulty describing specific drug information; benefits for including normalizing statements before asking for sensitive information; and challenges processing categorical frequency scales. Important content areas for inclusion included dose timing, disclosure, stigma, and food insecurity. CONCLUSIONS: Cognitive interviewing is a productive strategy for increasing the face validity and understandability of adherence measurement items, particularly across cultures. Interviews in Kenya suggested adherence measurement modifications of relevance for other resource-limited settings.
Authors: Kara Wools-Kaloustian; Silvester Kimaiyo; Lameck Diero; Abraham Siika; John Sidle; Constantin T Yiannoutsos; Beverly Musick; Robert Einterz; Kenneth H Fife; William M Tierney Journal: AIDS Date: 2006-01-02 Impact factor: 4.177
Authors: Winnie Bikaako-Kajura; Emmanuel Luyirika; David W Purcell; Julia Downing; Frank Kaharuza; Jonathan Mermin; Samuel Malamba; Rebecca Bunnell Journal: AIDS Behav Date: 2006-07
Authors: Joseph Mamlin; Sylvester Kimaiyo; Stephen Lewis; Hannah Tadayo; Fanice Komen Jerop; Catherine Gichunge; Tomeka Petersen; Yuehwern Yih; Paula Braitstein; Robert Einterz Journal: Am J Public Health Date: 2008-12-04 Impact factor: 9.308
Authors: C Reddington; J Cohen; A Baldillo; M Toye; D Smith; C Kneut; A Demaria; J Bertolli; H W Hsu Journal: Pediatr Infect Dis J Date: 2000-12 Impact factor: 2.129
Authors: Rachel C Vreeman; Sarah E Wiehe; Samwel O Ayaya; Beverly S Musick; Winstone M Nyandiko Journal: J Acquir Immune Defic Syndr Date: 2008-10-01 Impact factor: 3.731
Authors: Rachel C Vreeman; Winstone M Nyandiko; Edwin Sang; Beverly S Musick; Paula Braitstein; Sarah E Wiehe Journal: Confl Health Date: 2009-04-04 Impact factor: 2.723
Authors: L Coombes; K Bristowe; C Ellis-Smith; J Aworinde; L K Fraser; J Downing; M Bluebond-Langner; L Chambers; F E M Murtagh; R Harding Journal: Qual Life Res Date: 2021-03-18 Impact factor: 4.147
Authors: Rachel C Vreeman; Winstone M Nyandiko; Hai Liu; Wanzhu Tu; Michael L Scanlon; James E Slaven; Samuel O Ayaya; Thomas S Inui Journal: AIDS Behav Date: 2015-04
Authors: Musonda Simwinga; Moses K Kumwenda; Russell J Dacombe; Lusungu Kayira; Agness Muzumara; Cheryl C Johnson; Pitchaya Indravudh; Euphemia L Sibanda; Lot Nyirenda; Karin Hatzold; Elizabeth L Corbett; Helen Ayles; Miriam Taegtmeyer Journal: J Int AIDS Soc Date: 2019-03 Impact factor: 5.396
Authors: Rachel C Vreeman; Michael L Scanlon; Wanzhu Tu; James E Slaven; Carole I McAteer; Stephen J Kerr; Torsak Bunupuradah; Sararut Chanthaburanum; Karl-Günter Technau; Winstone M Nyandiko Journal: J Int AIDS Soc Date: 2019-05 Impact factor: 5.396
Authors: Rachel C Vreeman; Michael L Scanlon; Irene Marete; Ann Mwangi; Thomas S Inui; Carole I McAteer; Winstone M Nyandiko Journal: AIDS Care Date: 2015